The investigational Evident test requires 3 tumor markers on the same extracellular vesicle to flag early-stage ovarian cancer.
|Articles|August 5, 2011
Fibrocystic Breast Disease
Author(s)Arati Patnaik, MD, Surendra Nath Panda, MS
Advertisement
Advertisement
Related to this article
The prospective SOARA study will measure how often a 98%-specific ovarian cancer screening blood test leads to invasive procedures.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Before Pregnancy Begins: Why the Timing of Carrier Screening Matters
2
Neurokinin receptor antagonists improve menopausal sleep disturbance
3
Stephanie Faubion, MD, on the first menopause therapy discussion
4
Brain fog at menopause: Separating normal change from dementia
5